SCIENTIFIC HUB

Follow the evidence.

20.703 articles found

Source record

Exploring the Potential of Indole-3-acetic Acid Arylhydrazone Hybrids for Parkinson's Disease Treatment: A Comprehensive Evaluation of Neuroprotective, MAOB Inhibitory, and Antioxidant Properties.

Anastassova N, Kondeva-Burdina M, Hristova-Avakumova N, Stefanova D, Rangelov M, Todorova N, Yancheva D.

ACS Chem Neurosci · 2025-03-11

DOI: 10.1021/acschemneuro.4c00838PMID: 40066901

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Discovery of potential Leonurine-based therapeutic lead MJ210 attenuates Parkinson's disease pathogenesis via NF-κB and MAPK pathways: Mechanistic insights from in vitro and in vivo rotenone models.

Gupta S, Jash M, Khan J, Garg S, Roy R, Arshi MU, Nayak P, Ghosh S.

Eur J Med Chem · 2025-03-11

DOI: 10.1016/j.ejmech.2025.117471PMID: 40090295

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Update on Treatments for Parkinson's Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.

de Bie RMA, Katzenschlager R, Swinnen BEKS, Peball M, Lim SY, Mestre TA, Perez Lloret S, Coelho M, Aquino C, Tan AH, Bruno V, Dijk JM, Heim B, Lin CH, Kauppila LA, Litvan I, Spijker R, Seppi K, Costa J, Sampaio C, Fox SH, Silverdale MA.

Mov Disord · 2025-03-08

DOI: 10.1002/mds.30162PMID: 40055961

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.